Home/Stocks/AURA

AURA

USD

Aura Biosciences Inc. Common Stock

$5.680-0.270 (-4.538%)

Real-time Price

Healthcare

Biotechnology

United States

Price Chart

Loading Chart...

Key Metrics

Market Metrics

Company Fundamentals

Trading Stats

Market Metrics

Open

$5.950

High

$5.960

Low

$5.630

Volume

0.05M

Company Fundamentals

Market Cap

352.8M

Industry

Biotechnology

Country

United States

Trading Stats

Avg Volume

0.24M

Exchange

NGM

Currency

USD

52-Week Range

Low $4.345Current $5.680High $11.29

AI Analysis Report

Last updated: Nov 3, 2025

AI-GeneratedData Source: Yahoo Finance, Bloomberg, SEC

AURA Biosciences (AURA): Mixed Signals Near $6.10 Support Level

News Sentiment: Positive Catalysts Without Market Conviction

Aura Biosciences received two bullish signals from analysts and corporate events:

H.C. Wainwright Conference Participation (Sep 3): Failed to generate immediate momentum despite potential for investor visibility.
Analyst Buy Rating (Aug 13): Maintained a $22 price target--360% above current prices--but the stock hasn’t responded.

Market reaction to news appears muted. While analyst commentary remains optimistic, shares have traded flat-to

Related News

Sep 3, 2025 · 11:00 AM

GlobeNewswire

Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ:AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function,